Stockscreener 앱 받기
154.07
0.91%
-1.41
시간 외 거래:
154.07
Cardinal Health Inc 주식(CAH)의 최신 뉴스
Cardinal Health (NYSE:CAH) Launches Innovative Single-Patient Monitoring System to Enhance Patient Care - simplywall.st
Cardinal Health Rolls Out Kendall DL Vital Signs Monitor - Medical Product Outsourcing
Cardinal Health (CAH) Launches Innovative Patient Monitoring Sys - GuruFocus
Cardinal Health launches new medical device for the continuous m - GuruFocus
Cardinal Health Launches New Medical Device For The Continuous Monitoring Of Three Essential Vital Signs In One System - marketscreener.com
Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system - marketscreener.com
Cardinal Health's New Medical Device Revolutionizes Patient Monitoring with 3-in-1 System for Critical Vitals - Stock Titan
Wells Fargo Upgrades Cardinal Health (CAH) Stock, Lifts PT - Insider Monkey
Cardinal Health (CAH) Receives Bullish Upgrade from Wells Fargo - GuruFocus
Cardinal Health stock, Cencora stock upgraded at Wells Fargo - Seeking Alpha
Medical Device Third-party Logistics Market Trends, - GlobeNewswire
Cardinal Health (CAH) Receives Target Price Upgrade from Wells F - GuruFocus
Cardinal Health (CAH) Receives Target Price Upgrade from Wells Fargo | CAH Stock News - GuruFocus
bioAffinity's Game-Changing Lung Cancer Test Gets Nationwide Boost Through Cardinal Health Partnership - Stock Titan
Leerink Partners Adjusts Price Target on Cardinal Health to $177 From $173, Maintains Outperform Rating - marketscreener.com
Cardinal Health (CAH) Receives Upgrade with Higher Price Target | CAH Stock News - GuruFocus
Cardinal Health (CAH) Receives Rating Upgrade from Analyst | CAH Stock News - GuruFocus
Fortune 500: Here's how Central Ohio companies ranked in this year's list - The Business Journals
Cardinal Health, Inc. (NYSE:CAH) is favoured by institutional owners who hold 89% of the company - Yahoo Finance
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand | The Insight Partners - GlobeNewswire Inc.
Interesting CAH Put And Call Options For July 11th - Nasdaq
Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now - 24/7 Wall St.
Nephron Research Adjusts Cardinal Health Price Target to $166 From $160 - marketscreener.com
Baird Adjusts Price Target on Cardinal Health to $181 From $170, Maintains Outperform Rating - marketscreener.com
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook? - Yahoo Finance
Cardinal Health, Inc. (NYSE:CAH) is a favorite amongst institutional investors who own 89% - simplywall.st
Cardinal Health, Inc. (NYSE:CAH) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector? - MSN
FY2025 EPS Estimate for Cardinal Health Boosted by Analyst - Defense World
Cardinal Health ($CAH) Is Paying a $109M Settlement to Investors — Here’s How to Get Your Share - TradingView
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health stock soars to all-time high of $155 By Investing.com - Investing.com South Africa
Cardinal Health stock soars to all-time high of $155 - Investing.com Australia
Jim Cramer On Cardinal Health (CAH) “They Are Impressive” - Insider Monkey
Jim Cramer On Cardinal Health (CAH) "They Are Impressive" - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Flora Growth (FLGC), Cardinal Health (CAH) and Zevra Therapeutics (ZVRA) - The Globe and Mail
CAH Q1 Earnings Call: Cardinal Health Misses Revenue Targets but Exceeds Profit Expectations Amid Tariff Headwinds - Yahoo Finance
Cardinal Health Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology - Yahoo Finance
Cardinal Health Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Cardinal Health Insiders Sold US$18m Of Shares Suggesting Hesitancy - Yahoo Finance
Cardinal Health (CAH) Faces Market Focus Amid Global Trade Talks - GuruFocus
Cardinal Health (CAH): Navigating Market Uncertainty | CAH Stock News - GuruFocus
JPMorgan Adjusts Cardinal Health Price Target to $156 From $145, Maintains Neutral Rating - marketscreener.com
Cardinal Health's (NYSE:CAH) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5107 - Yahoo Finance
Cardinal Health, Inc. (CAH): Among Billionaire Mason Hawkins’ Mid-Cap Stocks with Huge Upside Potential - Insider Monkey
-Charles River agrees with Elliott to add new directors, review business - marketscreener.com
Charles River to add new directors, review business in agreement with Elliott - marketscreener.com
Cardinal Health releases new report on the cell and gene therapy industry | CAH Stock News - GuruFocus
Cardinal Health releases new report on the cell and gene therapy industry - marketscreener.com
Cardinal Health (NYSE:CAH) Announces Dividend Increase to US$1 Per Share - simplywall.st
Cardinal Health Board of Directors Approves Quarterly Dividend | - GuruFocus
Cardinal Health (CAH) Boosts Quarterly Dividend and Revises Earnings Guidance - GuruFocus
Cardinal Health Raises Dividend by About 1% - MarketWatch
0.87%
1.49%
자본화:
|
볼륨(24시간):